Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Anthony, Tolcher"'
Autor:
Toshio Shimizu, John Powderly, Albiruni Abdul Razak, Patricia LoRusso, Kathy D. Miller, Steven Kao, Sarah Kongpachith, Catherine Tribouley, Michelle Graham, Brian Stoll, Maulik Patel, Mohammad Sahtout, Martha Blaney, Rachel Leibman, Talia Golan, Anthony Tolcher
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundTransforming growth factor (TGF)-ß1 is a pleiotropic cytokine that can promote tumor growth and suppress antitumor immune responses. Latent TGF-ß1 associates with glycoprotein-A repetition predominant (GARP) on the surface of regulatory T
Externí odkaz:
https://doaj.org/article/ecaf119bc00648e1807c616981421d5c
Autor:
John Powderly, Alexander Spira, Shunsuke Kondo, Toshihiko Doi, Jason J. Luke, Drew Rasco, Bo Gao, Minna Tanner, Philippe A. Cassier, Anas Gazzah, Antoine Italiano, Diego Tosi, Daniel E. Afar, Apurvasena Parikh, Benjamin Engelhardt, Stefan Englert, Stacie L. Lambert, Sreeneeranj Kasichayanula, Sven Mensing, Rajeev Menon, Gregory Vosganian, Anthony Tolcher
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 1, Pp 277-287 (2021)
Budigalimab is a humanized, recombinant, Fc mutated IgG1 monoclonal antibody targeting programmed cell death 1 (PD‐1) receptor, currently in phase I clinical trials. The safety, efficacy, pharmacokinetics (PKs), pharmacodynamics (PDs), and budigali
Externí odkaz:
https://doaj.org/article/2e9537a22ea94fefa65b2b3c6cd4e048
Autor:
Xiaoyu Zhang, Anthony M Joshua, Sanjeev Kaul, Scott Antonia, Robert L Ferris, Roger B Cohen, Ezio Bonvini, Jan Baughman, Victoria Atkinson, Charu Aggarwal, Nicholas Vogelzang, Osama Rahma, Mahesh Seetharam, Yanyan Lou, Anthony Tolcher, Fernanda I Arnaldez, Amy Prawira, Ralph Hauke, Vinod Ganju, Andrew Weickhardt, Dan P Zandberg, Arash Rezazadeh Kalebasty, Alex A Adjei, Ariel Birnbaum, Rosetta Cavallo, Linda Peng, Paul A Moore, Stacie M Goldberg, Nehal J Lakhani
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/195a4377dadb4e879675192629df7c9e
Autor:
Michael Gordon, Anthony Tolcher, James Strauss, Rick Sorensen, Marianna Zavodovskaya, Ping Cheng Yi, Audrey Goddard, Matthew Peach, Kathleen Mahoney, Xiaoyun Yang, Kai-Wen Lin, Biao Li, Anna Seto, Tianling Chen, Juliane Jürgensmeier
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/347886e0b29943a29b63e012d170d625
Autor:
Alexander Chung, Omid Hamid, Manish Patel, Drew Rasco, Robert Andtbacka, Anthony Tolcher, Melissa Johnson, David Sommerhalder, Lixin Li
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/026c81833a1148d49b9084261fda7408
Autor:
Omid Hamid, Anthony Tolcher, Martin Gutierrez, Elaine Shum, Linda Liu, Solomon Langermann, Zachary Cusumano, Han Myint, Jahangheer Shaik, Emilia Barbu, Qinjie Zhou, Aaron Morawski, Hasan Abukharma, Megan Nelson, Stephanie Zeidan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/c5eba482ad174f67b95c9569cbbd6a38
Autor:
Sen Zhang, Aung Naing, Meredith McKean, Anthony Tolcher, Geoffrey Watson, Anja Victor, Vadryn Pierre, Emilia Richter
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/05d977ad742f45e999225509d2835f6b
Autor:
David S. Hong, Michael Postow, Bartosz Chmielowski, Ryan Sullivan, Amita Patnaik, Ezra E.W. Cohen, Geoffrey Shapiro, Conor Steuer, Martin Gutierrez, Heather Yeckes-Rodin, Robert Ilaria, Brenda O'Connell, Joanna Peng, Guangbin Peng, Nora Zizlsperger, Anthony Tolcher, Jedd D. Wolchok
Publikováno v:
Clinical Cancer Research. :OF1-OF10
Purpose: Eganelisib (IPI-549) is a first-in-class, orally administered, highly selective PI3Kγ inhibitor with antitumor activity alone and in combination with programmed cell death protein 1/ligand 1 (PD-1/PD-L1) inhibitors in preclinical studies. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb689ef9b775f6f85f59a874c6618855
https://doi.org/10.1158/1078-0432.ccr-22-3313
https://doi.org/10.1158/1078-0432.ccr-22-3313
Autor:
Nicholas Wilson, Richard Carvajal, Irina Shapiro, Anthony Tolcher, Dhan Chand, Marc Van Dijk, Anna Wijatyk, Jennifer Buell, James Strauss, Claire Galand, Vignesh Venkatraman, Marilyn Marques, Min Lim, Benjamin Morin, Olga Ignatovich, Mark Findeis, Dennis Underwood, Lernik Ohanjanian, David Savitsky
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/91057e4b0fe44f10b2f362fe7939da70
Autor:
Jedd D. Wolchok, Anthony Tolcher, Nora Zizlsperger, Guangbin Peng, Joanna Peng, Brenda O'Connell, Robert Ilaria, Heather Yeckes-Rodin, Martin Gutierrez, Conor Steuer, Geoffrey Shapiro, Ezra E.W. Cohen, Amita Patnaik, Ryan Sullivan, Bartosz Chmielowski, Michael Postow, David S. Hong
Study IPI-549-01 progression-free survival censoring rules for efficacy analyses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3449dda81899432179d1e7829050dfc0
https://doi.org/10.1158/1078-0432.22700464
https://doi.org/10.1158/1078-0432.22700464
